MiMedx Group Inc (MDXG) Lifted to “B” at TheStreet

TheStreet upgraded shares of MiMedx Group Inc (NASDAQ:MDXG) from a c+ rating to a b rating in a research note issued to investors on Thursday morning.

A number of other brokerages also recently weighed in on MDXG. First Analysis reiterated a hold rating on shares of MiMedx Group in a research report on Monday, December 12th. Needham & Company LLC reiterated a strong-buy rating and issued a $12.00 price target on shares of MiMedx Group in a research report on Wednesday, December 21st. Zacks Investment Research upgraded shares of MiMedx Group from a sell rating to a hold rating in a research report on Tuesday, February 21st. Finally, Piper Jaffray Companies assumed coverage on shares of MiMedx Group in a research report on Friday, March 3rd. They issued an overweight rating and a $10.00 price target on the stock. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. MiMedx Group presently has a consensus rating of Buy and an average price target of $11.00.

Analyst Recommendations for MiMedx Group (NASDAQ:MDXG)

Shares of MiMedx Group (NASDAQ:MDXG) opened at 8.94 on Thursday. The firm has a 50-day moving average of $8.24 and a 200-day moving average of $8.63. The firm has a market capitalization of $947.94 million, a PE ratio of 81.27 and a beta of 0.97. MiMedx Group has a 1-year low of $6.64 and a 1-year high of $10.02.

MiMedx Group (NASDAQ:MDXG) last announced its quarterly earnings results on Thursday, February 23rd. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.08 by $0.03. The firm earned $69.90 million during the quarter, compared to analyst estimates of $71.13 million. MiMedx Group had a net margin of 8.75% and a return on equity of 18.18%. The business’s revenue was up 34.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.07 earnings per share. On average, equities research analysts anticipate that MiMedx Group will post $0.30 EPS for the current fiscal year.

Your IP Address:

Several hedge funds have recently made changes to their positions in MDXG. Victory Capital Management Inc. increased its stake in shares of MiMedx Group by 68.7% in the third quarter. Victory Capital Management Inc. now owns 12,742 shares of the company’s stock worth $109,000 after buying an additional 5,189 shares in the last quarter. Arizona State Retirement System increased its stake in shares of MiMedx Group by 1.2% in the third quarter. Arizona State Retirement System now owns 52,316 shares of the company’s stock worth $449,000 after buying an additional 600 shares in the last quarter. Berkeley Capital Partners LLC increased its stake in shares of MiMedx Group by 2.4% in the third quarter. Berkeley Capital Partners LLC now owns 23,881 shares of the company’s stock worth $205,000 after buying an additional 553 shares in the last quarter. Wells Fargo & Company MN increased its stake in shares of MiMedx Group by 5.8% in the third quarter. Wells Fargo & Company MN now owns 1,094,784 shares of the company’s stock worth $9,393,000 after buying an additional 60,415 shares in the last quarter. Finally, Mesirow Financial Investment Management Equity Management increased its stake in shares of MiMedx Group by 5,502.5% in the third quarter. Mesirow Financial Investment Management Equity Management now owns 1,311,834 shares of the company’s stock worth $11,257,000 after buying an additional 1,288,419 shares in the last quarter. Institutional investors and hedge funds own 50.47% of the company’s stock.

MiMedx Group Company Profile

MiMedx Group, Inc (MiMedx) is an integrated developer, processor and marketer of regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues and human skin and bone. The Company operates in the Regenerative Biomaterials business segment, which includes the development, processing and marketing of regenerative biomaterial products and bioimplants processed from human amniotic membrane and other birth tissues in the wound care, surgical, sports medicine, ophthalmic and dental market categories.

5 Day Chart for NASDAQ:MDXG

Receive News & Ratings for MiMedx Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiMedx Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Nike Suspends Relationship with Maria Sharapova
Nike Suspends Relationship with Maria Sharapova
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Rob Bironas Ex-Titans Kicker Dies in Car Crash
Ron Washington Leaves Texas Rangers Due to an Affair
Ron Washington Leaves Texas Rangers Due to an Affair
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Jonathan Dwyer Falls in Line with Other Banned NFL Players
Tony Stewart Case Going to the Grand Jury
Tony Stewart Case Going to the Grand Jury
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder
Oscar Pistorius “Blade Runner” Found Not Guilty of Murder


Leave a Reply

 
© 2006-2017 Web Breaking News.